Cargando…

EFFECT OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ON CHEMOTHERAPY-INDUCED ORAL MUCOSITIS IN NON-NEUTROPENIC CANCER PATIENTS

OBJECTIVE: The study was designed to assess prospectively the efficacy of granulocyte-macrophage colony-stimulating factor (GM-CSF) in the management of chemotherapy-induced oral mucositis in non-neutropenic cancer patients. MATERIAL AND METHODS: In a prospective open study, adult cancer patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ibrahim, Ezzeldin M., Al-Mulhim, Fatma A., Al-Muhanna, Fahd A., Al-Amri, Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 1998
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437118/ https://www.ncbi.nlm.nih.gov/pubmed/23008581

Ejemplares similares

Effect of granulocyte colony-stimulating factor (G-CSF) on chemotherapy-induced oral mucositis
por: Katano, Mitsuo, et al.
Publicado: (1995)

Is there a place for granulocyte colony-stimulating factor in non-neutropenic critically ill patients?
por: Azoulay, Élie, et al.
Publicado: (2004)

Monocyte deactivation in neutropenic acute respiratory distress syndrome patients treated with granulocyte colony-stimulating factor
por: Mokart, Djamel, et al.
Publicado: (2008)

Thrombin Stimulates Synthesis of Macrophage Colony-Stimulating Factor, Granulocyte-Macrophage Colony-Stimulating Factor and Granulocyte Colony-Stimulating Factor by Human Proximal Tubular Epithelial Cells in Culture
por: Shimaya, Yuko, et al.
Publicado: (2012)

Magnetic Resonance Imaging of the Spine: An Initial Experience
por: Al-Mulhim, Fatma A., et al.
Publicado: (1994)

Risk factors for neutropenic fever in non- Hodgkin’s lymphoma patients with primary granulocyte colony-stimulating factor prophylaxis
por: Kim, Yu Ri, et al.
Publicado: (2021)

Granulocyte, granulocyte–macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells
por: Pei, X-H, et al.
Publicado: (1999)

Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis
por: Bo, Lulong, et al.
Publicado: (2011)

Hematopoietic Properties of Granulocyte Colony-Stimulating Factor/Immunoglobulin (G-CSF/IgG-Fc) Fusion Proteins in Normal and Neutropenic Rodents
por: Cox, George N., et al.
Publicado: (2014)

Evaluating the Prognostic Role of Monocytopenia in Chemotherapy-Induced Febrile Neutropenia Patients Treated with Granulocyte Colony-Stimulating Factor
por: Alshari, Osama, et al.
Publicado: (2021)

Current status of granulocyte–macrophage colony-stimulating factor in the immunotherapy of melanoma
por: Kaufman, Howard L, et al.
Publicado: (2014)

Granulocyte-macrophage colony stimulating factor in COVID-19: friend or foe?
por: Mehta, Puja, et al.
Publicado: (2021)

Granulocyte-macrophage colony-stimulating factor: an immunotarget for sepsis and COVID-19
por: Mu, Xiuying, et al.
Publicado: (2021)

Granulocyte‐macrophage colony‐stimulating factor: Conductor of the wound healing orchestra?
por: Ead, J. Karim, et al.
Publicado: (2023)

Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
por: Advani, S. H., et al.
Publicado: (2010)

Use of granulocyte colony-stimulating factor in patients with chemotherapy-induced neutropaenia
por: Shokane, Lucky L., et al.
Publicado: (2023)

Enhancement of Cytosine Arabinoside Cytotoxicity by Granulocyte/Macrophage Colony‐stimulating Factor and Granulocyte Colony‐stimulating Factor in a Human Myeloblastic Leukemia Cell Line
por: Takauji, Rumiko, et al.
Publicado: (1993)

Comparison of the effects of pegylated granulocyte-colony stimulating factor and granulocyte-colony stimulating factor on cytopenia induced by dose-dense chemotherapy in breast cancer patients
por: Ashrafi, Farzaneh, et al.
Publicado: (2018)

The Impact of Granulocyte Colony-Stimulating Factor Administration in a Neutropenic Cancer Patient With COVID-19-Related Acute Respiratory Distress Syndrome
por: Mohamed, Ayman, et al.
Publicado: (2023)

Intranasal administration of cationic liposomes enhanced granulocyte–macrophage colony-stimulating factor expression and this expression is dispensable for mucosal adjuvant activity
por: Tada, Rui, et al.
Publicado: (2018)

Immunostimulation using granulocyte- and granulocyte-macrophage colony stimulating factor in patients with severe sepsis and septic shock
por: Schefold, Joerg C
Publicado: (2011)

Transcriptional mechanisms underlying sensitization of peripheral sensory neurons by Granulocyte-/Granulocyte-macrophage colony stimulating factors
por: Bali, Kiran Kumar, et al.
Publicado: (2013)

The hematopoietic cytokine granulocyte-macrophage colony stimulating factor is important for cognitive functions
por: Krieger, Markus, et al.
Publicado: (2012)

Letter in Reply: Chronic Diseases Management Using Digital Health Technologies
por: Al Kuwaiti, Ahmed, et al.
Publicado: (2019)

Granulocyte colony-stimulating factor and leukemogenesis.
por: de Figueiredo, Lorena Lobo, et al.
Publicado: (2004)

The Prognostic Utility of Lymphocyte-Based Measures and Ratios in Chemotherapy-Induced Febrile Neutropenia Patients following Granulocyte Colony-Stimulating Factor Therapy
por: Halalsheh, Omar M., et al.
Publicado: (2022)

Granulocyte Colony Stimulating Factor (G-CSF) Induced Splenic Infarction in Breast Cancer Patient Treated with Dose-Dense Chemotherapy Regimen
por: Alshamrani, Majed A., et al.
Publicado: (2019)

Characterization of the cell surface receptor for human granulocyte/macrophage colony-stimulating factor
Publicado: (1986)

Granulocyte-macrophage colony-stimulating factor as an immune-based therapy in HIV infection
por: Brown, Pierre Antoine, et al.
Publicado: (2005)

Acute lung injury following the use of granulocyte-macrophage colony-stimulating factor
por: Kudlak, Kristina, et al.
Publicado: (2013)

Granulocyte-Macrophage Colony-Stimulating Factor Production and Tissue Eosinophilia in Chronic Rhinitis
por: Peric, Aleksandar, et al.
Publicado: (2016)

Role of granulocyte macrophage colony stimulating factor in regeneration of the central nervous system
por: Shanmugalingam, Ushananthini, et al.
Publicado: (2016)

Granulocyte-Macrophage Colony-Stimulating Factor as a Therapeutic Target in Multiple Sclerosis
por: Aram, Jehan, et al.
Publicado: (2018)

The Role of Granulocyte-Macrophage Colony-Stimulating Factor in Murine Models of Multiple Sclerosis
por: Monaghan, Kelly L., et al.
Publicado: (2020)

Neutralizing Anti-Granulocyte Macrophage-Colony Stimulating Factor Autoantibodies Recognize Post-Translational Glycosylations on Granulocyte Macrophage-Colony Stimulating Factor Years Before Diagnosis and Predict Complicated Crohn’s Disease
por: Mortha, Arthur, et al.
Publicado: (2022)

Inhibition of the immunosuppressive activity of resident pulmonary alveolar macrophages by granulocyte/macrophage colony-stimulating factor
Publicado: (1993)

Evaluation of effectiveness of granulocyte-macrophage colony-stimulating factor therapy to cancer patients after chemotherapy: a meta-analysis
por: Yu, Wen-Liang, et al.
Publicado: (2018)

Central inhibition of granulocyte-macrophage colony-stimulating factor is analgesic in experimental neuropathic pain
por: Nicol, Louise S.C., et al.
Publicado: (2018)

Systematic review of the use of granulocyte–macrophage colony-stimulating factor in patients with advanced melanoma
por: Hoeller, Christoph, et al.
Publicado: (2016)

Treatment with Molgramostim (Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor, Rhugm-Csf, Mielogen) and Lenograstim (Granulocyte-Colony Stimulating Factor) Improves Experimental Colitis in Rats
por: Papalois, Apostolos E., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rc3aoqntbi0vded8rvdd1esnbh